OGD/R-PC12 cells: the complete culture medium was removed and the PC12 cells cultured for 24 h were washed twice with sugar-free DMEM, then incubated with sugar-free DMEM in a closed anoxic chamber with 5% CO2 and 95% N2 at 37 ℃ for 2 h. The cells were then switched to a complete culture medium, and incubated in an incubator at constant temperature of 37 ℃ with 5% CO2 for 24 h. When PC12 cells were treated with NOB or NOB + pentanoic acid (PA, Med Chem Express, NJ, USA) after oxygen-glucose deprivation, MTT assay, flow cytometry and cell migration assay were performed.
Dulbecco modified eagle medium (dmem)
DMEM (Dulbecco's Modified Eagle Medium) is a cell culture medium commonly used in laboratory settings to support the growth and maintenance of a variety of cell types. It provides essential nutrients, vitamins, and other components necessary for cell proliferation and survival.
Lab products found in correlation
12 protocols using dulbecco modified eagle medium (dmem)
In Vitro Model of Ischemia-Reperfusion Injury
OGD/R-PC12 cells: the complete culture medium was removed and the PC12 cells cultured for 24 h were washed twice with sugar-free DMEM, then incubated with sugar-free DMEM in a closed anoxic chamber with 5% CO2 and 95% N2 at 37 ℃ for 2 h. The cells were then switched to a complete culture medium, and incubated in an incubator at constant temperature of 37 ℃ with 5% CO2 for 24 h. When PC12 cells were treated with NOB or NOB + pentanoic acid (PA, Med Chem Express, NJ, USA) after oxygen-glucose deprivation, MTT assay, flow cytometry and cell migration assay were performed.
Eugenol Neuroprotection in Cerebral I/R Injury
To mimic cerebral I/R injury in vitro, HT22 cells were subjected to oxygen-glucose deprivation/reperfusion (OGD/R) treatment. Briefly, HT22 cells were incubated in DMEM without glucose and FBS at 37 °C in 0.5% O2 and 5% CO2 for 12 h and then cultured in normal culture condition as described above for 24 h. To determine the protective effect of eugenol, HT22 cells were pretreated with various concentrations of eugenol at 24 h before the exposure to OGD/R. The inhibitor of AMPK pathway, compound C (10 μM, MedChemExpress, Shanghai, China) was added to HT22 cells at 1 h before the administration with 100 μM eugenol.
In Vitro Evaluation of Glucose-Lowering Drugs
Cannabinoid Receptor 2 Modulation in Hepatocellular Carcinoma
CB2 siRNA1: 5′-CCAGGTCAAGAAGGCCTTT-3′;
CB2 siRNA2: 5′- GCTTGGATTCCAACCCTAT-3′;
CB2 siRNA3: 5′-CCTGGCCAGTGTGGTCTTT-3′;
siNC: 5′-UUCUCCGAACGUGUCACGUTT-3.
Ibuprofen Cytotoxicity Assay in C643 and OCUT-2C Cells
Purification and Application of Isotalatizidine
Generating Bone Marrow-Derived Macrophages
Photoreceptor Cell Line for AGE and Metformin Research
Modeling Stroke and Reperfusion in HT-22 Neurons
Evaluating Hydroxycholesterol Effects on BMSCs
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!